Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025GlobeNewsWire • 02/13/25
Vericel (VCEL) Is a Great Choice for 'Trend' Investors, Here's WhyZacks Investment Research • 02/03/25
Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionBenzinga • 01/15/25
Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability TargetsGlobeNewsWire • 01/14/25
Hunting For Magnificent Growth Next Year? Check Out These 7 Stocks.Investors Business Daily • 12/03/24
Vericel Corporation (VCEL) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/07/24
Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024GlobeNewsWire • 08/29/24
Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal BurnsGlobeNewsWire • 08/15/24
Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024GlobeNewsWire • 08/07/24
7 Best Stocks For Magnificent Earnings Growth Next Year. See Who's New.Investors Business Daily • 07/30/24
Vericel Announces Appointment of Karen Mahoney as Chief Human Resources OfficerGlobeNewsWire • 07/22/24
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024GlobeNewsWire • 06/11/24